Publication:
Fluorescence-guided extended pelvic lymphadenectomy during robotic radical prostatectomy

dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorArmutlu, Ayşe
dc.contributor.kuauthorAykanat, İbrahim Can
dc.contributor.kuauthorBalbay, Mevlana Derya
dc.contributor.kuauthorBarçın, Erinç
dc.contributor.kuauthorBaydar, Dilek Ertoy
dc.contributor.kuauthorCanda, Abdullah Erdem
dc.contributor.kuauthorÇil, Barbaros Erhan
dc.contributor.kuauthorEsen, Tarık
dc.contributor.kuauthorFalay, Fikri Okan
dc.contributor.kuauthorKordan, Yakup
dc.contributor.kuauthorKöseoğlu, Ersin
dc.contributor.kuauthorKulaç, İbrahim
dc.contributor.kuauthorÖzkan, Arif
dc.contributor.kuauthorSarıkaya, Ahmet Furkan
dc.contributor.kuauthorTarım, Kayhan
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-10T00:09:39Z
dc.description.abstractWe evaluated and described the impact of prostatic indocyanine green (ICG) injection on extended pelvic lymph node (LN) dissection (ePLND) in robotic-assisted radical prostatectomy (RARP). Between January 2019 and December 2021, we included consecutive 50 PCa patients who underwent ePLND during RARP with (n = 25) or without (n = 25) prostatic ICG injection. ICG injection was performed during abdominal port placement and robot docking. Pelvic LNs reflecting green color were initially excised and then the template was completed. The outcomes of two groups were compared. Overall, nine (36%) and five (20%) of the patients had metastatic LN involvement in the ICG and non-ICG groups, respectively. Of the 509 dissected LNs in the ICG group, 122 (23.9%) were fluorescence active. 20 LNs (3.9%) were metastatic in this group, 9 (45%) of which were ICG+. 408 LNs were resected on the non-ICG group with 8(1.9%) being metastatic. Eight (88.9%) of nine pN+ patients were florescent positive in the ICG group. Out of six patients with pN+ disease, Ga68 PSMA-PET/CT detected positive LNs preoperatively. In addition to preoperative Ga68 PSMA-PET/CT investigation, ICG-guided ePLND might increase identification and removal of metastatic LNs duirng RARP. Improvements in staging and oncologic outcomes may also be seen in intermediate- and high-risk patients.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.identifier.doi10.1007/s11701-022-01480-z
dc.identifier.eissn1863-2491
dc.identifier.issn1863-2483
dc.identifier.scopus2-s2.0-85141215359
dc.identifier.urihttps://doi.org/10.1007/s11701-022-01480-z
dc.identifier.urihttps://hdl.handle.net/20.500.14288/17166
dc.identifier.wos878489000002
dc.keywordsIndocyanine green
dc.keywordsProstate cancer
dc.keywordsPelvic lymph node (LN) dissection
dc.language.isoeng
dc.publisherSpringernature
dc.relation.ispartofJournal of Robotic Surgery
dc.subjectSurgery
dc.titleFluorescence-guided extended pelvic lymphadenectomy during robotic radical prostatectomy
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorÖzkan, Arif
local.contributor.kuauthorKöseoğlu, Ersin
local.contributor.kuauthorCanda, Abdullah Erdem
local.contributor.kuauthorÇil, Barbaros Erhan
local.contributor.kuauthorAykanat, İbrahim Can
local.contributor.kuauthorSarıkaya, Ahmet Furkan
local.contributor.kuauthorTarım, Kayhan
local.contributor.kuauthorArmutlu, Ayşe
local.contributor.kuauthorKulaç, İbrahim
local.contributor.kuauthorBarçın, Erinç
local.contributor.kuauthorFalay, Fikri Okan
local.contributor.kuauthorKordan, Yakup
local.contributor.kuauthorBaydar, Dilek Ertoy
local.contributor.kuauthorBalbay, Mevlana Derya
local.contributor.kuauthorEsen, Tarık
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files